Maize (Zea mays L.) is a key cereal crop in global agriculture, supplying nutrition, feedstock, and industrial raw materials (Shiferaw 2021). Its significance stems not only from its economic value but also from its remarkable genetic diversity and adaptability (Mikel 2018). To enhance maize productivity and resilience to the current and projected climate changes, doubled haploid (DH) breeding emerges as a powerful tool, offering accelerated breeding cycles and precise genetic manipulation (Prasanna 2012). DH breeding in maize allows breeders (1) to accelerate the development of elite inbred lines for hybrid seed production and (2) the introgression of exotic germplasm for trait improvement. DH technology accelerates the development of new maize varieties tailored to the diverse needs of farmers and consumers by simplifying the breeding process and eliminating recurrent self-pollination and generations of backcrossing. Thus, DH breeding is gaining prominence in commercial breeding programs due to its benefits in accelerating the release of new hybrids and realizing increased genetic gain per year (Melchinger & Würschum 2010).
Unlike the traditional inbred line production protocol, the DH method facilitates development of homozygous inbred lines in two generations (one year). Generation 1 entails haploid induction. Generation 2 involves selfing fertile haploids to produce 100% homozygous DH lines (Trentin et al. 2020; Gupta et al. 2022). Currently, DH technology utilizes chemical doubling agents to induce haploid genome doubling and, subsequently, haploid male fertility. The resulting plants are doubled haploids (DHs) (Chaikam et al. 2019). In most cases, the haploid plants are chimeras comprising an assortment of both haploid and homozygous diploid cell lines but are still referred to as haploids or D0 generation (Xu et al. 2007).
Practically, the DH inbred line production protocol involves (1) crossing of two inbred parents to produce an F1. (2) F1 plants or other donor plants are planted and pollinated with an inducer genotype to obtain putative haploid kernels. (3) Kernels from induction crosses are harvested and sorted into hybrids and putative haploid kernels using a phenotypic marker (R1-Navajo). (4) Putative haploid seed is planted in seedling trays in the greenhouse, and seedlings are treated with the chemical colchicine to induce haploid genome doubling. (5) These haploid plants (D0 plants) are transplanted into the field, and false positive plants (hybrids resulting from the cross between inducer and donor) are rogued. (6) Male and female fertile haploids are self-pollinated to produce 100% homozygous DH lines (DH1 seeds) (Chang & Coe, 2009; Chaikam et al. 2019). DH lines can be released as a variety in self-pollinating crops like wheat, barley, rapeseed, and rice (Hale et al. 2021).
Haploid plants are sterile by nature. They contain only one set of chromosomes (Li et al. 2021). For haploid plants to produce seeds, they must be artificially initiated by colchicine treatment to double their genomes to produce fertile reproductive organs. Success in genome doubling results in fertile male and female inflorescence, also called haploid fertility (Trampe et al. 2020). Haploid fertility encompasses haploid male fertility (HMF) and haploid female fertility (HFF) (Fig. 1). HMF is the ability of haploid plants to produce fertile anthers and viable pollen, while HFF is the ability of the ear to set at least one seed after pollination. With colchicine treatment, HMF is reported to be low, while HFF does seem not to be limiting, with approximately 97 to 100% of haploids producing seeds when pollinated by diploid plants (Chalyk 1994).
Colchicine can be harmful to humans; its application is laborious and time-consuming and is associated with high greenhouse costs and governmental restrictions on handling and disposal of colchicine (Melchinger et al. 2013). Moreover, colchicine treatment typically confers a genome doubling rate of approximately 10–30%. Thus, haploid genome doubling remains a bottleneck to large-scale DH production due to low genome doubling rates presented by colchicine treatment (Boerman et al. 2020).
Here, we examine a trait called spontaneous haploid genome doubling (SHGD). SHGD occurs when a haploid plant duplicates its genome without applying colchicine. While most haploids are sterile, some genotypes display doubling rates exceeding 50% (Boerman et al. 2020). It has been shown that SHGD is heritable, involving both major and minor genes (Molenaar et al. 2019; Trampe et al. 2020; Ren et al. 2020; Foster et al. 2024). Genome doubling can occur during mitosis or meiosis, leading to fertile female and male inflorescences (Wu et al. 2014; Sugihara et al. 2013; Trampe et al. 2020). Unlike the colchicine-mediated DH protocol, the SHGD-mediated DH protocol entails (1) crossing two inbred parents to produce an F1. (2) F1 plants are planted and pollinated with an inducer genotype. (3) These kernels are harvested, and putative haploid kernels are identified. (4) Putative haploid seed is planted directly in the field, and false positive plants are rogued. (5) The male fertile haploids are self-pollinated to produce 100% homozygous DH lines. SHGD also presents the opportunity to breed seeds suitable for organic production since it allows breeders to omit colchicine in the protocol.
Inbred line A427 exhibits a high haploid male fertility (~ 78%) and carries a major QTL for SHGD (Trampe et al. 2020; Verzegnazzi et al. 2021). The major SHGD QTL, which has been shown to increase HMF, has been introgressed to over 200 BS39-derived lines (Santos et al. 2022). However, there exists a gap in knowledge regarding whether (1) haploid female fertility (HFF) restoration, without colchicine application, is adequate to yield ears with optimal seed set after pollination (2) and whether there are genomic regions, influencing both haploid female fertility and male fertility in the haploids derived through spontaneous haploid genome doubling (SHGD).
Thus, the objectives of the study were to (1) evaluate genetic variation for HFF in BS39 with and without the major QTL shown to increase HMF, (2) determine the relationship between HFF and HMF, and (3) identify genomic regions for both HFF and HMF in a genome-wide association study (GWAS).